|
|
| MRD / Regn No. |
: THBC\23-24\02660 |
Date |
: 07/07/2026 |
| Patient Name |
: Savita Wayadande |
Age & Gender |
: 52 Yrs. / Female |
| Contact No. |
: 9820547125 |
UHID |
: |
| Ht / Wt / BMI |
: 153 / 87.85 / 37.53 |
BP S / BP D |
: 131 / 83 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
|
Subjective |
: |
T2DM X 3 YEARS,SMALL FIBRE NEUROPATHY,SUBCLINICAL HYPOTHYROIDISM,H/O RETINAL HOLE,PAIN DUE TO NEUROPATHY,TOLERATED RYBELSUS WELL - NO DIFF WT / SUGAR |
|
Objective |
: |
JULY 26- FBS-112.6/PP- 115.82/HBA1C- 7.2 |
|
Plan |
: |
ADDING SEMANEXT - TO REDUCE GLIMISAVE M1 TO 0.5 / THEN 0.5 MG OD AND THEN STOP |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET GLIMEPIRIDE (1MG) AND METFORMIN (500MG)
GLIMISAVE M1 |
ORAL |
0-0-1 |
BEFORE DINNER
|
3 MTHS |
|
|
2 |
DRISE 60,000 |
ORAL |
1/MTH |
ANYTIME
|
3 MTHS |
|
|
3 |
GLIMISAVE M 0.5 MG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
4 |
SHELCAL XT |
ORAL |
0-1-0 |
AL / 3 DAYS A WEEK
|
3 MTHS |
|
|
5 |
TABLET DAPAGLIFLOZIN (10MG)
UDAPA 10 MG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
6 |
TELROSE 40+10 MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
7 |
SAROGLITAZAAR 4 MG
LIPAGLYN 4 MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
8 |
INJ SEMANEXT 0.25 MG |
SC |
ONCE EVERY WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
9 |
INJ SEMANEXT 0.5 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
10 |
INJ SEMANEXT 1 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 07/Oct/2026 |
| Tests Suggested For Next Visit |
: HBA1C / FBS / PPBS > 3 MTHS |
| |
|
| |
|
